United Therapeutics
UTHR
UTHR
531 hedge funds and large institutions have $9.89B invested in United Therapeutics in 2023 Q4 according to their latest regulatory filings, with 75 funds opening new positions, 201 increasing their positions, 169 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
1% less capital invested
Capital invested by funds: $10B → $9.89B (-$148M)
27% less call options, than puts
Call options by funds: $24.8M | Put options by funds: $33.9M
44% less funds holding in top 10
Funds holding in top 10: 18 → 10 (-8)
Holders
531
Holding in Top 10
10
Calls
$24.8M
Puts
$33.9M
Top Buyers
| 1 | +$124M | |
| 2 | +$105M | |
| 3 | +$52.2M | |
| 4 |
BlackRock
New York
|
+$40.3M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$26.7M |
Top Sellers
| 1 | -$72.1M | |
| 2 | -$69.4M | |
| 3 | -$62.4M | |
| 4 |
ITP
Iron Triangle Partners
Cos Cob,
Connecticut
|
-$47.6M |
| 5 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$39.6M |